Differences between the Health Assessment Questionnaire Disability Index (HAQ-DI) and the modified HAQ (mHAQ) score before and after infliximab treatment in patients with rheumatoid arthritis.

Modern rheumatology / the Japan Rheumatism Association

Volumn 20, Issue 4, 2010, Pages 337-342

  Nagasawa, Hayato ^a   Kameda, Hideto ^b   Sekiguchi, Naoya ^b   Amano, Koichi ^b   Takeuchi, Tsutomu ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; INFLIXIMAB; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DAILY LIFE ACTIVITY; DISABILITY; DRUG EFFECT; DRUG MONITORING; FEMALE; HEALTH STATUS; HUMAN; JOINT; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISABILITY EVALUATION; DRUG MONITORING; FEMALE; HEALTH STATUS; HUMANS; JOINTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78349258976     PISSN: None     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-010-0284-8     Document Type: Article

References (0)